TradingKey

mehr Informationen über Clarivate PLC Unternehmen

Clarivate Plc is a global provider of transformative intelligence. The Company offers enriched data, insights and analytics, workflow solutions and expert services in the areas of Academia & Government (A&G), Intellectual Property (IP) and Life Sciences & Healthcare (LS&H). Within the A&G segment, the Company provides research and analytics, content aggregation, and workflow software solutions. Within the IP segment, the Company provides IP Maintenance, IP Intelligence, and IP Management solutions. Within the LS&H segment, the Company provides research and development, regulatory and safety, and commercialization solutions. It is also a provider of cloud-based solutions that enable life sciences clients to automate regulatory reporting and compliance management. It is also engaged in providing comprehensive and integrated solutions to support patent preparation, filing and prosecution, offering patent practitioners with automation and artificial intelligence (AI)-enabled solutions.

Unternehmensinformationen

BörsenkürzelCLVT

Name des UnternehmensClarivate PLC

IPO-datumOct 29, 2018

Gegründet am2019

CEOMr. Matitiahu Shem (Matti) Tov

Anzahl der mitarbeiter12000

WertpapierartOrdinary Share

GeschäftsjahresendeOct 29

Addresse70 St. Mary Axe

StadtLONDON

BörseNYSE Consolidated

LandUnited Kingdom

PostleitzahlEC3A 8BE

Telefon442074334000

Websitehttps://clarivate.com/

BörsenkürzelCLVT

IPO-datumOct 29, 2018

Gegründet am2019

Führungskräfte

Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Bar Veinstein

President - Academia and Government

729.15K

+150.40%

Mr. Jonathan Mark Collins

Chief Financial Officer, Executive Vice President

488.98K

+10.04%

Mr. Henry Levy

President - Life Sciences and Health care

411.80K

-8.81%

Dr. Saurabh Saha, M.D., Ph.D.

Independent Director

116.52K

+42.06%

Dr. Wendell E. Pritchett

Independent Director

101.81K

+41.73%

Ms. Valeria Alberola

Independent Director

91.16K

+57.91%

Mr. Kenneth L. Cornick

Director

29.95K

--

Mr. Jane Okun Bomba, CPA

Independent Director

--

Ms. Suzanne Heywood

Independent Director

--

Mr. Usama N. Cortas

Independent Director

--

Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Bar Veinstein

President - Academia and Government

729.15K

+150.40%

Mr. Jonathan Mark Collins

Chief Financial Officer, Executive Vice President

488.98K

+10.04%

Mr. Henry Levy

President - Life Sciences and Health care

411.80K

-8.81%

Dr. Saurabh Saha, M.D., Ph.D.

Independent Director

116.52K

+42.06%

Dr. Wendell E. Pritchett

Independent Director

101.81K

+41.73%

Ms. Valeria Alberola

Independent Director

91.16K

+57.91%

Umsatzaufteilung

Währung: USDAktualisiert: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Subscription revenues

388.60M

65.45%

Re-occurring revenues

105.90M

17.84%

Transactional revenues

99.20M

16.71%

Nach RegionUSD

Name

Umsatz

Anteil

Americas

321.10M

54.08%

Europe/ Middle East /Africa

151.70M

25.55%

Asia Pacific

120.90M

20.36%

Nach Geschäftsbereich

Nach Region

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Subscription revenues

388.60M

65.45%

Re-occurring revenues

105.90M

17.84%

Transactional revenues

99.20M

16.71%

Aktionärsstatistik

Aktualisiert: Wed, Jul 2

Aktionäre

Aktionärstypen

Aktionäre

Anteil

Leonard Green & Partners, L.P.

17.36%

Clarkston Capital Partners, LLC

11.09%

Giovanni Agnelli B V

10.01%

Impactive Capital LP

6.40%

Onex Corporation

6.24%

Other

48.91%

Aktionäre

Anteil

Leonard Green & Partners, L.P.

17.36%

Clarkston Capital Partners, LLC

11.09%

Giovanni Agnelli B V

10.01%

Impactive Capital LP

6.40%

Onex Corporation

6.24%

Other

48.91%

Aktionärstypen

Aktionäre

Anteil

Private Equity

30.46%

Investment Advisor

29.45%

Hedge Fund

14.74%

Investment Advisor/Hedge Fund

12.61%

Holding Company

9.85%

Corporation

5.58%

Pension Fund

1.75%

Individual Investor

1.03%

Sovereign Wealth Fund

0.85%

Institutionelle Beteiligung

Aktualisiert: Tue, Jul 1

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2025Q2

647

749.14M

111.46%

-141.21M

2025Q1

695

750.51M

109.86%

-167.62M

2024Q4

712

766.77M

110.84%

-166.20M

2024Q3

726

765.53M

108.25%

-158.23M

2024Q2

741

760.08M

105.78%

-120.39M

2024Q1

752

730.14M

108.67%

-137.39M

2023Q4

783

725.50M

108.90%

-179.38M

2023Q3

791

741.16M

111.25%

-79.71M

2023Q2

796

712.25M

105.35%

-100.17M

2023Q1

777

702.68M

104.01%

-43.46M

Aktionärsaktivitäten

Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

Leonard Green & Partners, L.P.

116.67M

17.08%

--

Mar 31, 2025

Clarkston Capital Partners, LLC

74.53M

10.91%

+3.79M

+5.36%

Mar 31, 2025

Giovanni Agnelli B V

67.29M

9.85%

--

Mar 31, 2025

Impactive Capital LP

43.03M

6.3%

--

Mar 31, 2025

Onex Corporation

41.92M

6.14%

-938.25K

-2.19%

Mar 10, 2025

Selige Co-Investor Pooling SCSp

38.09M

5.58%

--

Mar 10, 2025

Partners Group AG

25.58M

3.75%

--

Mar 31, 2025

Cambridge Information Group, Inc.

23.90M

3.5%

+290.94K

+1.23%

Mar 10, 2025

Dimensional Fund Advisors, L.P.

16.59M

2.43%

+2.13M

+14.75%

Mar 31, 2025

Fidelity Investments Canada ULC

16.19M

2.37%

+902.39K

+5.90%

Mar 31, 2025

Verbundene ETFs

Aktualisiert: 11 hours ago

Name

Anteil

AGF US Market Neutral Anti-Beta Fund

0.52%

First Trust Technology Alphadex

0.31%

Avantis US Small Cap Value ETF

0.2%

WisdomTree US MidCap Fund

0.19%

JPMorgan US Value Factor ETF

0.18%

DFA Dimensional US Small Cap Value ETF

0.16%

John Hancock Multifactor Small Cap ETF

0.14%

Nuveen ESG Small-Cap ETF

0.13%

BNY Mellon US Small Cap Core Equity ETF

0.09%

Strive Small-Cap ETF

0.08%

AGF US Market Neutral Anti-Beta Fund

Anteil0.52%

First Trust Technology Alphadex

Anteil0.31%

Avantis US Small Cap Value ETF

Anteil0.2%

WisdomTree US MidCap Fund

Anteil0.19%

JPMorgan US Value Factor ETF

Anteil0.18%

DFA Dimensional US Small Cap Value ETF

Anteil0.16%

John Hancock Multifactor Small Cap ETF

Anteil0.14%

Nuveen ESG Small-Cap ETF

Anteil0.13%

BNY Mellon US Small Cap Core Equity ETF

Anteil0.09%

Strive Small-Cap ETF

Anteil0.08%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Keine Daten

Aktien-Split

Datum

Art

Verhältnis

Keine Daten

Datum

Art

Verhältnis

Keine Daten

Clarivate PLC

3.620USD

Clarivate PLC

3.620

Übersicht

Unternehmen

Finanzen